Cargando…
High rate of hepatitis B reactivation during tyrosine kinase inhibitor treatment among patients with chronic myeloid leukemia in Korea
| Autores principales: | , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9812728/ https://www.ncbi.nlm.nih.gov/pubmed/36419239 http://dx.doi.org/10.5045/br.2022.2022099 |
| _version_ | 1784863793231167488 |
|---|---|
| author | Kong, Jee Hyun Jang, Jae Yeon Ko, Tae Hwa Kang, Seong Hee Kim, Yundeok |
| author_facet | Kong, Jee Hyun Jang, Jae Yeon Ko, Tae Hwa Kang, Seong Hee Kim, Yundeok |
| author_sort | Kong, Jee Hyun |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9812728 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-98127282023-01-30 High rate of hepatitis B reactivation during tyrosine kinase inhibitor treatment among patients with chronic myeloid leukemia in Korea Kong, Jee Hyun Jang, Jae Yeon Ko, Tae Hwa Kang, Seong Hee Kim, Yundeok Blood Res Letters to the Editor Korean Society of Hematology; Korean Society of Blood and Marrow Transplantation; Korean Society of Pediatric Hematology-Oncology; Korean Society on Thrombosis and Hemostasis 2022-12-31 2022-12-31 /pmc/articles/PMC9812728/ /pubmed/36419239 http://dx.doi.org/10.5045/br.2022.2022099 Text en © 2022 Korean Society of Hematology https://creativecommons.org/licenses/by-nc/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0 (https://creativecommons.org/licenses/by-nc/4.0/) ) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Letters to the Editor Kong, Jee Hyun Jang, Jae Yeon Ko, Tae Hwa Kang, Seong Hee Kim, Yundeok High rate of hepatitis B reactivation during tyrosine kinase inhibitor treatment among patients with chronic myeloid leukemia in Korea |
| title | High rate of hepatitis B reactivation during tyrosine kinase inhibitor treatment among patients with chronic myeloid leukemia in Korea |
| title_full | High rate of hepatitis B reactivation during tyrosine kinase inhibitor treatment among patients with chronic myeloid leukemia in Korea |
| title_fullStr | High rate of hepatitis B reactivation during tyrosine kinase inhibitor treatment among patients with chronic myeloid leukemia in Korea |
| title_full_unstemmed | High rate of hepatitis B reactivation during tyrosine kinase inhibitor treatment among patients with chronic myeloid leukemia in Korea |
| title_short | High rate of hepatitis B reactivation during tyrosine kinase inhibitor treatment among patients with chronic myeloid leukemia in Korea |
| title_sort | high rate of hepatitis b reactivation during tyrosine kinase inhibitor treatment among patients with chronic myeloid leukemia in korea |
| topic | Letters to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9812728/ https://www.ncbi.nlm.nih.gov/pubmed/36419239 http://dx.doi.org/10.5045/br.2022.2022099 |
| work_keys_str_mv | AT kongjeehyun highrateofhepatitisbreactivationduringtyrosinekinaseinhibitortreatmentamongpatientswithchronicmyeloidleukemiainkorea AT jangjaeyeon highrateofhepatitisbreactivationduringtyrosinekinaseinhibitortreatmentamongpatientswithchronicmyeloidleukemiainkorea AT kotaehwa highrateofhepatitisbreactivationduringtyrosinekinaseinhibitortreatmentamongpatientswithchronicmyeloidleukemiainkorea AT kangseonghee highrateofhepatitisbreactivationduringtyrosinekinaseinhibitortreatmentamongpatientswithchronicmyeloidleukemiainkorea AT kimyundeok highrateofhepatitisbreactivationduringtyrosinekinaseinhibitortreatmentamongpatientswithchronicmyeloidleukemiainkorea |